| 000 | 01570 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517175633.0 | ||
| 264 | 0 | _c20181101 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1359-4117 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAfzal, Muhammad Zubair | |
| 245 | 0 | 0 |
_aA retrospective analysis of tolerance and outcomes of cutaneous malignant melanoma in patients receiving adjuvant interferon-alpha 2B: a community oncology perspective. _h[electronic resource] |
| 260 |
_bJournal of experimental therapeutics & oncology _cSep 2017 |
||
| 300 |
_a91-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aDepression _xepidemiology |
| 650 | 0 | 4 |
_aFatigue _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xepidemiology |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMelanoma, Cutaneous Malignant |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aPinnamaneni, Vani | |
| 700 | 1 | _aBirendra, K C | |
| 700 | 1 | _aDavis, Alan T | |
| 700 | 1 | _aKoehler, Tracy J | |
| 700 | 1 | _aLakhani, Nehal | |
| 773 | 0 |
_tJournal of experimental therapeutics & oncology _gvol. 11 _gno. 2 _gp. 91-96 |
|
| 999 |
_c27629683 _d27629683 |
||